Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Rxi Pharmaceuticals (RXII)

Rxi Pharmaceuticals (RXII)
0.33 unch (unch) 11/16/18 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Fri, Nov 16th, 2018
Day Low
0.32
Day High
0.33
Open 0.33
Previous Close 0.33 0.33
Volume 461,100 461,100
Avg Vol 1,725,540 1,725,540
Stochastic %K 10.53% 10.53%
Weighted Alpha -94.27 -94.27
5-Day Change -0.10 (-23.26%) -0.10 (-23.26%)
52-Week Range 0.31 - 7.70 0.31 - 7.70
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,445
  • Shares Outstanding, K 4,380
  • Annual Sales, $ 20 K
  • Annual Income, $ -12,450 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.07
  • Price/Sales 96.28
  • Price/Cash Flow N/A
  • Price/Book 0.83
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.30
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.10
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.11
  • Prior Year -0.84
  • Growth Rate Est. (year over year) +88.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.31 +6.45%
on 11/15/18
Period Open: 0.45
0.50 -34.00%
on 11/08/18
-0.12 (-26.67%)
since 10/16/18
3-Month
0.31 +6.45%
on 11/15/18
Period Open: 1.52
2.19 -84.93%
on 09/27/18
-1.19 (-78.29%)
since 08/16/18
52-Week
0.31 +6.45%
on 11/15/18
Period Open: 5.70
7.70 -95.71%
on 11/29/17
-5.37 (-94.21%)
since 11/16/17

Business Summary

RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. The Company is developing RXI-109, which is used for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.34
1st Resistance Point 0.33
Last Price 0.33
1st Support Level 0.32
2nd Support Level 0.32
3rd Support Level N/A

See More

52-Week High 7.70
Fibonacci 61.8% 4.88
Fibonacci 50% 4.01
Fibonacci 38.2% 3.13
Last Price 0.33
52-Week Low 0.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies